Free shipping on all orders over $ 500

Sodium Phenylbutyrate

Cat. No. M3022

All AbMole products are for research use only, cannot be used for human consumption.

Sodium Phenylbutyrate Structure
Synonym:

4-PBA sodium; 4-Phenylbutyric acid sodium; Sodium 4-phenylbutyrate; TriButyrate

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
100mg USD 60  USD60 In stock
200mg USD 95  USD95 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Sodium Phenylbutyrate (4-PBA sodium) is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.

Chemical Information
Molecular Weight 186.18
Formula C10H11O2.Na
CAS Number 1716-12-7
Solubility (25°C) Water ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Sabrina Paganoni, et al. Sodium Phenylbutyrate-Taurursodiol for ALS. Reply

[2] Joachim Herz, et al. Sodium Phenylbutyrate-Taurursodiol for ALS

[3] John Turnbull. Sodium Phenylbutyrate-Taurursodiol for ALS

[4] Sabrina Paganoni, et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis

[5] Sabrina Paganoni, et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis

Related HDAC Products
CM-444

CM-444 is an inhibitor for HDAC and DNA methyltransferases (DNMT) with IC50 values of 6 nM-0.6 μM and 1.8-2.3 μM, respectively. CM-444 is an inducer for the differentiation of acute myeloid leukemia cells. CM-444 exhibits anti-leukemic activity and improves the survival rate in mouse models.

CM-1758

CM-1758 is a histone deacetylase (HDAC) inhibitor. CM-1758 inhibits tumor growth in vivo. CM-1758 induces acetylation of non-histone proteins in acute myeloid leukemia cells.

T-518 

T-518 is an orally active, selective, and blood-brain barrier permeable HDAC6 inhibitor with an IC50 value of 36 nM for human HDAC6.

SE-7552 

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM.

BRD9757 

BRD9757 is a potent, capless and selective HDAC6 inhibitor with an IC50 of 30 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Sodium Phenylbutyrate, 4-PBA sodium; 4-Phenylbutyric acid sodium; Sodium 4-phenylbutyrate; TriButyrate supplier, HDAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.